Chemoinformaics analysis of (E)-Eremophila-1(10),7(11)-dien-12-yl acetate
| Molecular Weight | 262.393 | nRot | 2 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 13 |
| Exact Molecular Weight | 262.193 | nRing | 2 |
| Solubility: LogS | -4.309 | nHRing | 0 |
| Solubility: LogP | 4.508 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 47.3306 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.544 |
| Synth | 4.101 |
| Natural Product Likeliness | 2.14 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.967 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.551 |
| MDCK | 0.0000227 |
| BBB | 0.157 |
| PPB | 0.955581 |
| VDSS | 3.613 |
| FU | 0.0230394 |
| CYP1A2-inh | 0.307 |
| CYP1A2-sub | 0.181 |
| CYP2c19-inh | 0.208 |
| CYP2c19-sub | 0.828 |
| CYP2c9-inh | 0.232 |
| CYP2c9-sub | 0.469 |
| CYP2d6-inh | 0.044 |
| CYP2d6-sub | 0.531 |
| CYP3a4-inh | 0.424 |
| CYP3a4-sub | 0.288 |
| CL | 9.991 |
| T12 | 0.19 |
| hERG | 0.004 |
| Ames | 0.008 |
| ROA | 0.013 |
| SkinSen | 0.222 |
| Carcinogencity | 0.863 |
| EI | 0.481 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.75827 |